Catalyst Wire Dossier Catalyst Wire Dossier

HCV antigen peptide vaccine

· Valneva Austria GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HCV antigen peptide vaccine, covering 2012-10-19 to 2012-10-19. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine [Phase 2]

See pricing